Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1074172 | 1.00 | ALDH1A1 (0.50) | ALDH1A1LMNACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL1075141 | 0.73 | AR (0.35) | ALDH1A1LMNACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL1076798 | 0.72 | ALDH1A1 (0.42) | ALDH1A1LMNACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL1076796 | 0.72 | ALDH1A1 (0.42) | ALDH1A1LMNACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL13561199 | 0.72 | CYP1A2 (0.71) | ALDH1A1LMNACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL5092251 | 0.68 | HSD17B10 (0.40) | ALDH1A1LMNACYP1A2CYP2C19SMN1; SMN2 | |
| Phenyl(Methyl)Semicarbazone SCHEMBL17119918 | 0.67 | ALDH1A1 (1.00) | ALDH1A1LMNACYP1A2CYP2C9CYP2C19 | |
| Phenyl(Methyl)Semicarbazone SCHEMBL27835565 | 0.67 | ALDH1A1 (1.00) | ALDH1A1LMNACYP1A2CYP2C9CYP2C19 | |
| Phenyl(Methyl)Semicarbazone SCHEMBL28048924 | 0.67 | ALDH1A1 (1.00) | ALDH1A1LMNACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL13826733 | 0.65 | LMNA (0.59) | ALDH1A1LMNACYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110263610-A1 | COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS | IRM LLC (BM) | 2011-10-27 | — | — | US | disclosed |
| EP-2274302-A2 | COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS | IRM LLC (BM) | 2011-01-19 | — | — | EP | disclosed |
| WO-2009123948-A2 | COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS | IRM LLC (BM) | 2009-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263610-A1 | COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS | IP6K1, IP6K2, IP6K3 | ALDH1A1 4470/4885LMNA 2895/4885CYP1A2 4840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.